WEST PHARMACEUTICAL SERVICES, INC. Financial and Nonfinancial Liabilities, Fair Value Disclosure
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $18.60 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2026-07-23
- 2026-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $18.60M.
- 2026-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $16.60M.
- 2025-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $19.90M.
- 2025-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $39.90M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure as first filed |
|---|---|---|
| 2026-06-30 | $18.60M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $16.60M 10-Q · filed 2026-04-23 | |
| 2025-12-31 | $19.90M 10-Q · filed 2026-07-23 | |
| 2025-09-30 | $39.90M 10-Q · filed 2025-10-23 | |
| 2025-06-30 | $58.90M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $24.20M 10-Q · filed 2025-04-24 | |
| 2024-12-31 | $32.50M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $25.00M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $29.10M 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $24.10M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $16.20M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $25.40M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $36.40M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $17.50M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $18.80M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $26.30M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $25.60M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $23.90M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $23.20M 10-K · filed 2023-02-21 | |
| 2021-09-30 | $22.00M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $22.70M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $24.10M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $33.40M 10-K · filed 2022-02-22 | |
| 2020-09-30 | $34.00M 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $23.50M 10-Q · filed 2020-07-24 | |
| 2020-03-31 | $21.40M 10-Q · filed 2020-04-24 | |
| 2019-12-31 | $17.80M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $13.40M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $12.20M 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $13.00M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $11.70M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $21.50M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $22.90M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $16.80M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $19.90M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $22.40M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $23.40M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $17.90M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $19.00M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $16.00M 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $16.50M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $16.20M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $17.00M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $16.40M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $17.10M 10-Q · filed 2015-08-03 | |
| 2015-03-31 | $17.30M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $17.30M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $17.10M 10-Q · filed 2014-11-03 | |
| 2014-06-30 | $17.40M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $20.40M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $17.70M 10-K · filed 2015-02-25 | $22.00M 10-K · filed 2014-02-27 |
| 2013-09-30 | $21.70M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $423.20M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $458.40M 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $20.90M 10-K · filed 2014-02-27 | $406.90M 10-K · filed 2013-02-27 |
| 2012-09-30 | $386.50M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $316.40M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $305.90M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $294.70M 10-K · filed 2013-02-27 | $15.50M 10-K/A · filed 2012-03-01 |
| 2011-09-30 | $15.50M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $15.00M 10-Q/A · filed 2011-08-08 | |
| 2010-12-31 | $13.80M 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |